Tumor Biology 2011-10-01

A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces oxidative stress mediated selective radiosensitization of malignant cells via mitochondrial dysfunction.

Richa Bhardwaj, Pradeep Kumar Sharma, Suryaprakash Singh Jadon, Rajeev Varshney

Index: Tumour Biol. 32 , 951-964, (2011)

Full Text: HTML

Abstract

Oxidative stress-mediated mitochondrial dysfunction is known to induce intrinsic pathway of apoptosis. Previously, we have shown that a combination of metabolic modifiers 2-deoxy-D-glucose (2-DG) and 6-aminonicotinamide (6-AN) results in oxidative stress-mediated radiosensitization of malignant cells via noncoordinated expression of antioxidant defense. We now show that the combination (2-DG + 6-AN + 2Gy) induces significant alterations in mitochondrial membrane potential and oxidative damage to lipid and proteins selectively in malignant cells resulting in the release of cytochrome c from mitochondria and increase in Bax/Bcl-2 ratio stimulating intrinsic pathway of apoptosis, besides enhancing the mitotic death linked to cytogenetic damage. These results highlight the role of mitochondrial dysfunction in selective radiosensitization by 2-DG + 6-AN, besides inhibition of energy-linked DNA repair processes and generation of oxidative stress reported earlier.


Related Compounds

  • 2-Deoxy-D-glucose
  • 6-Aminonicotinamid...

Related Articles:

Autocrine/paracrine function of globular adiponectin: inhibition of lipid metabolism and inflammatory response in 3T3-L1 adipocytes.

2015-05-01

[J. Cell. Biochem. 116(5) , 754-66, (2015)]

Shiga toxin stimulates clathrin-independent endocytosis of the VAMP2, VAMP3 and VAMP8 SNARE proteins.

2015-08-01

[J. Cell Sci. 128 , 2891-902, (2015)]

Lactic acid is a sperm motility inactivation factor in the sperm storage tubules.

2015-01-01

[Sci. Rep. 5 , 17643, (2015)]

Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21.

2015-11-10

[Sci. Signal. 8 , ra113, (2015)]

Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR.

2014-01-01

[Nat. Commun. 5 , 5582, (2014)]

More Articles...